undefined
The trademark nurivit was filed by OLONEA ΕΤΕΡΟΡΡΥΘΜΗ ΕΤΑΙΡΕΙΑ ΕΜΠΟΡΙΑΣ ΠΑΡΑΦΑΡΜΑΚΕΥΤΙΚΩΝ ΕΙΔΩΝ, a corporation established under the laws of the Hellenic Republic (the "Applicant"). The application was published for oppositions on August 22, 2021, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on November 22, 2021 by Reckitt & Colman (Overseas) Health Limited on Likelihood of confusion. the opponent was represented by POTTER CLARKSON AB and its proceedings were handled in English The second opposition filed on November 3, 2021 by ABIOCOM on Likelihood of confusion. the opponent was represented by IPSIDE and its proceedings were handled in English
The application was filed in Greek, and Greek was also language of all opposition proceedings (English was selected as the second language).
Change of name and address of the trademark registration was recorded on March 14, 2022.
The Opposition with reference B 003157812 was rejected according to Article 8(1)(b) EUTMR with decision issued on February 15, 2023 by the EUIPO.